about
Identification of novel compounds inhibiting chikungunya virus-induced cell death by high throughput screening of a kinase inhibitor libraryA general mechanism for intracellular toxicity of metal-containing nanoparticles.New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.The Niemann-Pick C1 Inhibitor NP3.47 Enhances Gene Silencing Potency of Lipid Nanoparticles Containing siRNA.Endocytic pH regulates cell surface localization of glycolipid antigen loaded CD1d complexesIdentification of a New Benzimidazole Derivative as an Antiviral against Hepatitis C VirusInhibitory effect of chloroquine derivatives on presenilin 1 and ubiquilin 1 expression in Alzheimer's disease.Hydroxychloroquine augments early virological response to pegylated interferon plus ribavirin in genotype-4 chronic hepatitis C patients.Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseasesAnti-hepatitis C virus potency of a new autophagy inhibitor using human liver slices model.New use of an old drug: chloroquine reduces viral and ALT levels in HCV non-responders (a randomized, triple-blind, placebo-controlled pilot trial).Distribution of hydroxychloroquine in lymphoid tissue in a rabbit model for HIV infectionIntracellular Transport of Silver and Gold Nanoparticles and Biological Responses: An Update.Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.
P2860
Q28534763-1B8359E4-673C-406D-BF33-EC1D19EA588DQ33995502-812B1937-E5D7-41CA-AF05-D4C3C3534B84Q35914270-064589AE-1E59-4111-AF17-DB222B48EAC6Q36134911-90BBABB7-3936-40E9-9630-6652BBA11DE0Q36249071-6E0ED99B-C656-4B61-B420-6C641538545DQ37252935-5125FD79-A3E1-49DD-ABF1-C5F5A310DCBEQ38844585-C450467B-844F-4981-8176-26AC3B00990EQ39062828-6019053B-D12E-4DF2-BF9D-E3F907F0FE20Q39360987-ABE48A26-C77A-4652-9F53-46EAE79E0CFBQ40593359-201A47F5-48BA-4CD8-8EF1-ED383E047712Q40747582-01872EFA-3634-4788-BB52-BD8CF3B61B9DQ41907478-CAF74748-A7A0-4B8A-97A9-6778B9939B3DQ52558420-C4D054C3-7B60-4574-9DFF-E90444ED7A64Q53683152-A4CF2F73-5A10-4432-9D1C-23D0F8C73C85
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Lysosomotropic agents as HCV entry inhibitors.
@ast
Lysosomotropic agents as HCV entry inhibitors.
@en
Lysosomotropic agents as HCV entry inhibitors.
@nl
type
label
Lysosomotropic agents as HCV entry inhibitors.
@ast
Lysosomotropic agents as HCV entry inhibitors.
@en
Lysosomotropic agents as HCV entry inhibitors.
@nl
prefLabel
Lysosomotropic agents as HCV entry inhibitors.
@ast
Lysosomotropic agents as HCV entry inhibitors.
@en
Lysosomotropic agents as HCV entry inhibitors.
@nl
P2093
P2860
P356
P1433
P1476
Lysosomotropic agents as HCV entry inhibitors
@en
P2093
Sheikh Riazuddin
Sidra Rehman
Tariq Javed
Zafar Nawaz
P2860
P356
10.1186/1743-422X-8-163
P577
2011-04-12T00:00:00Z